_version_ 1784901574548520960
author Tay, Matthew Zirui
Goh, Yun Shan
Fong, Siew-Wai
Chang, Zi Wei
Rouers, Angeline
Wong, Nathan
Torres-Ruesta, Anthony
Huang, Yuling
Selvam, Sooriya Kannan
Hor, Pei Xiang
Loh, Chiew Yee
Wang, Bei
Mohd Salleh, Siti Nazihah
Ngoh, Eve Zi Xian
Lee, Raphael Tze Chuen
Neo, Vanessa
Kam, Isaac Kai Jie
Poh, Xuan Ying
Rao, Suma
Chia, Po Ying
Ong, Sean W.X.
Lee, Tau Hong
Lim, Clarissa
Teo, Jefanie
Maurer-Stroh, Sebastian
Wang, Cheng-I
Leo, Yee-Sin
Lin, Raymond Tzer Pin
Lye, David C.
Young, Barnaby Edward
Ng, Lisa F.P.
Renia, Laurent
author_facet Tay, Matthew Zirui
Goh, Yun Shan
Fong, Siew-Wai
Chang, Zi Wei
Rouers, Angeline
Wong, Nathan
Torres-Ruesta, Anthony
Huang, Yuling
Selvam, Sooriya Kannan
Hor, Pei Xiang
Loh, Chiew Yee
Wang, Bei
Mohd Salleh, Siti Nazihah
Ngoh, Eve Zi Xian
Lee, Raphael Tze Chuen
Neo, Vanessa
Kam, Isaac Kai Jie
Poh, Xuan Ying
Rao, Suma
Chia, Po Ying
Ong, Sean W.X.
Lee, Tau Hong
Lim, Clarissa
Teo, Jefanie
Maurer-Stroh, Sebastian
Wang, Cheng-I
Leo, Yee-Sin
Lin, Raymond Tzer Pin
Lye, David C.
Young, Barnaby Edward
Ng, Lisa F.P.
Renia, Laurent
author_sort Tay, Matthew Zirui
collection PubMed
description
format Online
Article
Text
id pubmed-9988436
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99884362023-03-07 Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant Tay, Matthew Zirui Goh, Yun Shan Fong, Siew-Wai Chang, Zi Wei Rouers, Angeline Wong, Nathan Torres-Ruesta, Anthony Huang, Yuling Selvam, Sooriya Kannan Hor, Pei Xiang Loh, Chiew Yee Wang, Bei Mohd Salleh, Siti Nazihah Ngoh, Eve Zi Xian Lee, Raphael Tze Chuen Neo, Vanessa Kam, Isaac Kai Jie Poh, Xuan Ying Rao, Suma Chia, Po Ying Ong, Sean W.X. Lee, Tau Hong Lim, Clarissa Teo, Jefanie Maurer-Stroh, Sebastian Wang, Cheng-I Leo, Yee-Sin Lin, Raymond Tzer Pin Lye, David C. Young, Barnaby Edward Ng, Lisa F.P. Renia, Laurent Lancet Reg Health West Pac Correspondence Elsevier 2023-03-07 /pmc/articles/PMC9988436/ /pubmed/37125085 http://dx.doi.org/10.1016/j.lanwpc.2023.100732 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Tay, Matthew Zirui
Goh, Yun Shan
Fong, Siew-Wai
Chang, Zi Wei
Rouers, Angeline
Wong, Nathan
Torres-Ruesta, Anthony
Huang, Yuling
Selvam, Sooriya Kannan
Hor, Pei Xiang
Loh, Chiew Yee
Wang, Bei
Mohd Salleh, Siti Nazihah
Ngoh, Eve Zi Xian
Lee, Raphael Tze Chuen
Neo, Vanessa
Kam, Isaac Kai Jie
Poh, Xuan Ying
Rao, Suma
Chia, Po Ying
Ong, Sean W.X.
Lee, Tau Hong
Lim, Clarissa
Teo, Jefanie
Maurer-Stroh, Sebastian
Wang, Cheng-I
Leo, Yee-Sin
Lin, Raymond Tzer Pin
Lye, David C.
Young, Barnaby Edward
Ng, Lisa F.P.
Renia, Laurent
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
title Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
title_full Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
title_fullStr Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
title_full_unstemmed Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
title_short Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
title_sort heterologous mrna vaccine boosters induce a stronger and longer-lasting antibody response against omicron xbb variant
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988436/
https://www.ncbi.nlm.nih.gov/pubmed/37125085
http://dx.doi.org/10.1016/j.lanwpc.2023.100732
work_keys_str_mv AT taymatthewzirui heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT gohyunshan heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT fongsiewwai heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT changziwei heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT rouersangeline heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT wongnathan heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT torresruestaanthony heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT huangyuling heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT selvamsooriyakannan heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT horpeixiang heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT lohchiewyee heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT wangbei heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT mohdsallehsitinazihah heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT ngohevezixian heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT leeraphaeltzechuen heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT neovanessa heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT kamisaackaijie heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT pohxuanying heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT raosuma heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT chiapoying heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT ongseanwx heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT leetauhong heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT limclarissa heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT teojefanie heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT maurerstrohsebastian heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT wangchengi heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT leoyeesin heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT linraymondtzerpin heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT lyedavidc heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT youngbarnabyedward heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT nglisafp heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant
AT renialaurent heterologousmrnavaccineboostersinduceastrongerandlongerlastingantibodyresponseagainstomicronxbbvariant